ENDOVASCULAR MANAGEMENT OF TYPE B ACUTE AORTIC DISSECTION IN NON-SYNDROMIC PATIENTS WITH A FAMILY HISTORY OF AORTIC DISEASE

While a genetic basis for thoracic aortic aneurysm and dissection is well established, little is known about endovascular stent graft therapy (TEVAR) outcomes in patients with family history of aortic disease following Type B acute aortic dissection (TBAD). Patients enrolled in the International